Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: Circ Cardiovasc Interv. 2021 Mar 15;14(4):e009927. doi: 10.1161/CIRCINTERVENTIONS.120.009927

Figure 4.

Figure 4.

Procedure indications and contraindications. A) Indications for TAVR-explant and B) Contraindications to redo TAVR. TAVR-explant indications were available for all patients, while contraindications to redo TAVR were determined for 34/46 (74%) patients. Some had more than one indication and/or contraindication. Patients with a need for other cardiac surgery also met ≥1 valve-related indications for TAVR-explant.